What was CARDINAL HEALTH INC's revenue in fiscal 2026?

CARDINAL HEALTH INC reported revenue of $254.25B for fiscal 2026, up 14.2% from fiscal 2025.

What is CARDINAL HEALTH INC's net margin?

Operating margin was 1.0% and net margin was 0.7%.

What is CARDINAL HEALTH INC's diluted EPS?

Diluted EPS was $7.23, up 12.1% from the prior year.

Are CARDINAL HEALTH INC insiders buying or selling shares?

Over the past 12 months, insiders reported 35 open-market sales totalling $61.6M on Form 4.

Which institutions hold CARDINAL HEALTH INC stock?

2,228 institutions reported holding CARDINAL HEALTH INC shares in 13F filings for the quarter ended June 30, 2026; the largest reported position was Vanguard Capital Management's.

Overview

CARDINAL HEALTH INC

CAHNYSEHealth CareWholesale-Drugs, Proprietaries & Druggists' SundriesCIK 0000721371Large-cap benchmark

Latest 10-K: FY2026, filed Aug 11, 2026 · Open the 10-K (Inline XBRL) ↗

Ask about CAH in Workspace

Revenue: $254.25B; 14.2%YoYup from FY2025; TotalRevenue
Gross profit: $9.77B; 19.7%YoYup from FY2025; GrossProfit
Operating income: $2.61B; 14.9%YoYup from FY2025; OperatingIncome
Net income: $1.71B; 9.8%YoYup from FY2025; NetIncome
Diluted EPS: $7.23; 12.1%YoYup from FY2025; EPSDiluted
Diluted shares: 237.0M; 2.1%YoYdown from FY2025; WeightedAvgSharesDiluted

At a glance

Growth

CARDINAL HEALTH INC reported revenue of $254.25B for fiscal 2026, up 14.2% from fiscal 2025.
Revenue grew faster than the median S&P 500 member in 3 of the last 4 fiscal years.

Profitability

Operating margin was 1.0% and net margin was 0.7%.

Per share

Diluted EPS was $7.23, up 12.1% from the prior year.

Insiders & holders

Over the past 12 months, insiders reported 35 open-market sales totalling $61.6M on Form 4.
2,228 institutions reported holding CARDINAL HEALTH INC shares in 13F filings for the quarter ended June 30, 2026; the largest reported position was Vanguard Capital Management's.

Written from the filed figures on this page by fixed rules — no AI.

Data as of Oct 30, 2026 · Sources: SEC EDGAR 10-K, Form 4, 13F

Quick answers

What was CARDINAL HEALTH INC's revenue in fiscal 2026?: CARDINAL HEALTH INC reported revenue of $254.25B for fiscal 2026, up 14.2% from fiscal 2025.
What is CARDINAL HEALTH INC's net margin?: Operating margin was 1.0% and net margin was 0.7%.
What is CARDINAL HEALTH INC's diluted EPS?: Diluted EPS was $7.23, up 12.1% from the prior year.
Are CARDINAL HEALTH INC insiders buying or selling shares?: Over the past 12 months, insiders reported 35 open-market sales totalling $61.6M on Form 4.
Which institutions hold CARDINAL HEALTH INC stock?: 2,228 institutions reported holding CARDINAL HEALTH INC shares in 13F filings for the quarter ended June 30, 2026; the largest reported position was Vanguard Capital Management's.

Data as of Oct 30, 2026 · Sources: SEC EDGAR 10-K

Financial statements

Annual figures from the 10-K, most recent fiscal year first.

Income Statement

5 annual periods

Chip: YoY change.

Income Statement, annual, newest fiscal year first. 4Y CAGR: compound annual growth from the oldest to the newest year shown. Muted line: large-cap benchmark median change. Line under a label: how many large-cap benchmark companies its median rests on.
Line item	FY2026	FY2025	FY2024	FY2023	FY2022	4Y CAGR
Revenue	$254.25B14.2%up	$222.58B1.9%down Benchmark median 6.4%	$226.83B10.7%up Benchmark median 4.5%	$204.98B13.0%up Benchmark median 4.8%	$181.33B11.6%up Benchmark median 10.3%	8.8%
Gross Profit Median of 315 / 498	$9.77B19.7%up	$8.17B10.2%up Benchmark median 6.8%	$7.41B7.9%up Benchmark median 5.5%	$6.87B6.0%up Benchmark median 5.2%	$6.48B4.3%down Benchmark median 8.3%	10.8%
Operating Income Median of 373 / 498	$2.61B14.9%up	$2.27B83.0%up Benchmark median 7.3%	$1.24B65.3%up Benchmark median 7.4%	$0.75Bn/m Benchmark median 4.9%	negative: -$0.61B228.6%down Benchmark median 7.5%	n/m
Net Income	$1.71B9.8%up	$1.56B83.2%up Benchmark median 4.8%	$0.85B158.2%up Benchmark median 5.7%	$0.33Bn/m Benchmark median 1.9%	negative: -$0.94B253.5%down Benchmark median 1.3%	n/m
EPS (Diluted)	$7.2312.1%up	$6.4587.0%up Benchmark median 6.2%	$3.45173.8%up Benchmark median 7.9%	$1.26n/m Benchmark median 1.9%	negative: -$3.37262.0%down Benchmark median 1.5%	n/m

Balance Sheet

5 annual periods

Chip: YoY change.

Balance Sheet, annual, newest fiscal year first. 4Y CAGR: compound annual growth from the oldest to the newest year shown. Muted line: large-cap benchmark median change. Line under a label: how many large-cap benchmark companies its median rests on.
Line item	FY2026	FY2025	FY2024	FY2023	FY2022	4Y CAGR
Total Assets	$57.30B7.9%up	$53.12B17.7%up Benchmark median 5.6%	$45.12B4.1%up Benchmark median 3.4%	$43.35B1.2%down Benchmark median 4.1%	$43.88B1.3%down Benchmark median 2.2%	6.9%
Total Liabilities Median of 357 / 498	—	—	—	—	—	—
Stockholders' Equity	negative: -$2.72Bn/m	negative: -$2.63Bn/m Benchmark median 6.8%	negative: -$3.21Bn/m Benchmark median 5.4%	negative: -$2.96Bn/m Benchmark median 7.3%	negative: -$0.88B154.3%down Benchmark median 2.5%	n/m
Cash & Equivalents	$4.86B25.3%up	$3.87B24.5%down Benchmark median 5.2%	$5.13B25.9%up Benchmark median 1.9%	$4.08B13.6%down Benchmark median 6.7%	$4.72B38.5%up Benchmark median -8.6%	0.7%
Total Debt	$8.89B4.2%up	$8.53B67.5%up Benchmark median 2.1%	$5.09B8.3%up Benchmark median 0.2%	$4.70B11.6%down Benchmark median 0.3%	$5.32B14.8%down Benchmark median 0.1%	13.7%

Cash Flow Statement

5 annual periods

Chip: YoY change.

Cash Flow Statement, annual, newest fiscal year first. 4Y CAGR: compound annual growth from the oldest to the newest year shown. Muted line: large-cap benchmark median change. Line under a label: how many large-cap benchmark companies its median rests on.
Line item	FY2026	FY2025	FY2024	FY2023	FY2022	4Y CAGR
Operating Cash Flow	$5.17B115.9%up	$2.40B36.3%down Benchmark median 6.3%	$3.76B32.3%up Benchmark median 4.8%	$2.84B10.4%down Benchmark median 9.9%	$3.17B30.7%up Benchmark median -0.7%	13.0%
Capital Expenditures	$649.00M18.6%up	$547.00M7.0%up Benchmark median 5.4%	$511.00M6.2%up Benchmark median 2.8%	$481.00M24.3%up Benchmark median 11.3%	$387.00M3.2%down Benchmark median 14.0%	13.8%
Free Cash Flow Median of 378 / 498	$4.53B144.6%up	$1.85B43.1%down Benchmark median 7.3%	$3.25B37.6%up Benchmark median 6.1%	$2.36B15.2%down Benchmark median 8.8%	$2.79B37.4%up Benchmark median -11.3%	12.9%

n/m: not meaningful — the base (the prior year, or the first year for the CAGR) was zero or negative, or a per-share figure’s share basis changed (stock split). “—” means the figure is not available.

Benchmark median = median of the companies in the benchmark universe on Dec 31 of each fiscal year, from their own 10-K filings; a change counts only companies whose prior year was positive. Each median uses every member that reports the line item; where fewer than 80% do (banks and insurers file no gross profit), the row names how many. Published where at least 250 companies report it. Updated 2026-10-27. This compares reported figures, not share-price returns. Methodology

Ratios & valuation

FY2026

Every ratio read two ways: Wall Street’s popular formula and the value investor’s stricter one. Same question, same unit. Pick a ratio.

Valuation · Earnings yield

What a dollar of market value earned

3.0%

Wall Street

on net earnings

FY2025 3.8%

8.0%

Value investor

on free cash flow

FY2025 4.6%

Gap +5.0 pts: Value-investor figure 5.0 points higher

How it’s calculated

Wall Street · on net earnings

Diluted EPS ÷ fiscal-year-end share price (1 ÷ P/E)

pe_ratio (ratio table)

P/E 32.9×

Value investor · on free cash flow

(Operating cash flow − capital expenditures) ÷ market capitalisation (fiscal-year-end close × weighted-average diluted shares)

free cash flow ÷ market cap

Each ratio measures one thing two ways, in the same unit: the popular formula, then a stricter one, so a lower figure is the stricter reading. Gap = value-investor figure minus Wall Street figure, from the figures shown.

Price-based ratios use the fiscal-year-end closing price. Free cash flow = operating cash flow − capital expenditures (we compute it; filings rarely report it). n/m = not meaningful (denominator ≤ 0); “—” = not reported. Each ratio’s formulas are under “How it’s calculated”.

Cash & capital allocation

Where the cash went in FY2026, from the 10-K cash flow statement.

Operating cash flow: $5.17B
Capex: $649.00M
Free cash flow: $4.53B
R&D: —
Buybacks: $1.36B
Dividends: $491.00M
Debt repaid: $653.00M
Debt issued: $1.00B
Net debt change: $347.00M

Uses of operating cash flow, FY2026

Buybacks26.3%
Dividends9.5%
Capex12.5%
Debt repayment12.6%

Each use is shown against operating cash flow on its own; the uses overlap.

Buybacks + dividends exceeded free cash flow in FY2023.

Free cash flow by year

FY21$2.03B
FY22$2.79B
FY23$2.36B
FY24$3.25B
FY25$1.85B
FY26$4.53B

Buybacks by year

FY21$200.00M
FY22$1.00B
FY23$2.00B
FY24$750.00M
FY25$765.00M
FY26$1.36B

Smart money

Who is trading and holding CARDINAL HEALTH INC, from Form 4, 13F and 13D/13G filings.

Insiders

Insider activity · past 12 months

Open-market trades reported on Form 4 in the past 365 days.

Buys: 0; none reported
Sales: 35; 8 insiders
Value sold: $61.6M
Shares sold: 261,345
Net shares: -261,345; bought minus sold
Last trade: Aug 19, 2026

Purchases 0% of valueSales 100% of value

Latest open-market insider trades from Form 4
Insider	Type	Date	Shares	Price	Value	Filing
Scherer Mary C.Chief Accounting Officer	Sell	Aug 19, 2026	2,202	$237.39	$522,733	View filing on SEC EDGAR
Scherer Mary C.Chief Accounting Officer	Sell	Aug 19, 2026	100	$237.40	$23,740	View filing on SEC EDGAR
Hollar Jason M.Chief Executive Officer	Sell	Aug 19, 2026	6,244	$237.88	$1,485,323	View filing on SEC EDGAR

See plans

Open-market purchases (code P) and sales (code S) only. Grants, option exercises and tax withholding are excluded. Sales may be made under pre-arranged Rule 10b5-1 plans.

Ownership

Largest institutional holders

13F

Quarter ended Jun 30, 2026; change versus Mar 31, 2026.

Institutions reporting: 2,228
Top 3 hold: 18.0%; of 237.00M diluted shares, FY2026 10-K

Top 3 holders, share of diluted sharesof 100%

Vanguard Capital Management6.5%
15,292,186 sh · $3.6BAdded 0.0%13F-HR · Jun 30, 2026 on SEC EDGAR
Vanguard Portfolio Management5.8%
13,717,894 sh · $3.3BTrimmed 0.1%13F-HR · Jun 30, 2026 on SEC EDGAR
Wellington Management Company LLP5.8%
13,698,841 sh · $3.3BNo prior-quarter match13F-HR · Jun 30, 2026 on SEC EDGAR

See plans

Some filers' amendments could not be read, so a few holders may be counted twice.

Bars: share of diluted shares on a shared scale; the tick marks 5%. 13F filings are due 45 days after quarter end, so this is the latest fully reported quarter. Amended filings are counted once.

Blockholders, 5% and over

13D/G

SC 13D / 13G, latest filing per filer.

Filers at 5%+: 5
Combined: 38.8%; sum of latest filings
Activist (13D): 0

5%+ filers, share of the class as filedof 100%

BlackRock, Inc.13.3%
Passive · 13GLast filed 2 yrs agoSC 13G/A · Oct 24, 2024 on SEC EDGAR
Vanguard Capital Management7.49%
Passive · 13GSC 13G · Apr 29, 2026 on SEC EDGAR
Wellington Group Holdings LLP6.3%
Passive · 13GSC 13G · Aug 13, 2026 on SEC EDGAR

See plans

No filer switched from a passive 13G to an activist 13D in the last 365 days.

Percent of the class as each filer last reported it; filings older than a year may no longer reflect the stake. Latest filing per filer within three years; a later filing reporting 0% removes the filer.

Full history, every insider and 13F filer, 13D/G activist stakes, and webhooks are on Institutional.

See Institutional

Smart money

Showing the most recent 5 annual periods. Get longer history on the Pro plan, or the full history (1993–present) plus the smart-money dataset and webhooks on Institutional.

Restatement Radar

6 numbers CARDINAL HEALTH INC later changed — same XBRL tag, both filings linked.

numbers changed: 6
restating filings: 3
came with an amendment or a non-reliance notice: 0

Aug 26, 1996 · 10-K
changed 4 numbers
No amendment filed
Open filing
- Net incomeFY 1994$33.9M restated to $79.8M+135.3%
  As reported · Sep 2, 1994fds5:NET-INCOMEAny P/E built on the original was 57.5% too high.
- Pretax incomeFY 1994$70.8M restated to $146.9M+107.6%
  As reported · Sep 2, 1994fds5:INCOME-PRETAX
- Net incomeQ1 1994$16M restated to $28.3M+76.4%
  As reported · Nov 8, 1994fds5:NET-INCOMEAny P/E built on the original was 43.3% too high.
- Pretax incomeQ1 1994$27.7M restated to $48M+73.2%
  As reported · Nov 8, 1994fds5:INCOME-PRETAX
May 13, 1998 · 10-Q
changed 1 number
No amendment filed
Open filing
- Net incomeFY 1995$85M restated to $146.6M+72.5%
  As reported · Sep 21, 1995fds5:NET-INCOMEAny P/E built on the original was 42.0% too high.
Nov 1, 2024 · 10-Q
changed 1 number
No amendment filed
Open filing
- Operating incomeQ1 2023-$14M restated to -$32M−128.6%
  As reported · Nov 3, 2023us-gaap:OperatingIncomeLoss

CAH is not the only one.

See every restatement we've found across the market — or get an alert the next time CAH revises a number.

Restatement Radar Alert me

Restatements are detected by comparing every vintage of a fact across all of CARDINAL HEALTH INC's filings back to 1993. A revision is not by itself a sign of wrongdoing — companies re-file for many legitimate reasons. This list is not exhaustive: it shows CAH's most significant revisions, and a figure absent from it has not been certified as unrevised.

Peers, filings & research

Sector Peers

UNITEDHEALTH GROUP INC

MRK· Health Care

Merck & Co., Inc.

TMO· Health Care

THERMO FISHER SCIENTIFIC INC.

ABT· Health Care

ABBOTT LABORATORIES

ISRG· Health Care

INTUITIVE SURGICAL INC

AMGN· Health Care

AMGEN INC

Recent SEC filings

The six newest, periodic reports and 8-Ks together. Dates are SEC filing dates.

All filings on EDGAR

Six most recent SEC filings, newest first
Form	Filing	Filed	Document
8-K	Current report (material events) · Event dated Oct 1, 2026 0000721371-26-000041 · accepted 10:52 UTC	Oct 1, 2026	Open	Filed Oct 1, 2026 · 0000721371-26-000041
8-K	Current report (material events) · Event dated Aug 7, 2026 0000721371-26-000036 · accepted 10:38 UTC	Aug 11, 2026	Open	Filed Aug 11, 2026 · 0000721371-26-000036
10-K	Annual report · Fiscal year ended Jun 30, 2026 0000721371-26-000038 · accepted 12:57 UTC	Aug 11, 2026	Open	Filed Aug 11, 2026 · 0000721371-26-000038
10-Q	Quarterly report · Quarter ended Mar 31, 2026 0000721371-26-000018 · accepted 12:51 UTC	Apr 30, 2026	Open	Filed Apr 30, 2026 · 0000721371-26-000018
10-K/A	Annual report amendment · Fiscal year ended Jun 30, 2010 0001193125-10-203886 · accepted 20:03 UTC	Sep 2, 2010	Open	Filed Sep 2, 2010 · 0001193125-10-203886
10-Q/A	Quarterly report amendment · Quarter ended Sep 30, 1997 0000950152-98-000075 · accepted 15:00 UTC	Jan 7, 1998	Open	Filed Jan 7, 1998 · 0000950152-98-000075

“Open” goes to the Inline XBRL viewer when the filing has one, else the primary document. The accession opens the EDGAR index.

Research Reports

No published research on CAH yet.

Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows on data pinned to its SEC filing. Be the first: run equity_research_brief on CAH and publish the result to your public profile.

Browse the research catalog Generate one with your agent

The data behind this page

27 tables, history 1993–present. Every figure above is a row you can query.

Fundamentals

Standardized financial facts, ratios and filings.

fact: 121.4Mrows
ratio: 15.8Mrows
filing: 3.71Mrows
entity: 33,316rows

350+ standard concepts.

Built from these SEC forms

10-K
10-K/A
10-K405
10-K405/A
10-KT
10-KT/A
10-Q
10-Q/A
10-QT
10-QT/A
20-F
20-F/A
40-F
40-F/A
8-K
8-K/A
6-K
6-K/A
S-1
S-1/A
S-3
S-3/A
S-4
S-4/A
S-11
S-11/A
F-1
F-1/A
F-3
F-3/A
F-4
F-4/A
POS AM
10-KSB
10-KSB/A
10-QSB
10-QSB/A
DEF 14Asoon
DEF 14Csoon
DEFA14Asoon
PRE 14Asoon
DEFM14Asoon
425soon
SC TO-Tsoon
SC TO-Isoon
SC 14D9soon
SC 13E3soon
CORRESPsoon
NT 10-Ksoon
NT 10-Qsoon
NT 20-Fsoon
N-PORT-Psoon

Smart money

Insider and institutional filings.

institutional_holding: 88.6Mrows
insider_transaction: 12.1Mrows
insider_filing: 5.55Mrows
insider_ownership: 1.98Mrows

109M+ smart-money rows in all.

Built from these SEC forms

Form 3
Form 3/A
Form 4
Form 4/A
Form 5
Form 5/A
13F-HR
13F-HR/A
13F-NT
13F-NT/A
SC 13D
SC 13D/A
SC 13G
SC 13G/A
Form 144
Form 144/A

One real fact row for CARDINAL HEALTH INC

Fact receiptOperatingCashFlow

Operating cash flow · FY2026

$5.17B

5,174,000,000 USD

CARDINAL HEALTH INC reported Operating cash flow of $5.2B for fiscal year 2026 in its 10-K filed Aug 11, 2026.

Fiscal period: 2026 FY
Period end: 2026-06-30
Form: 10-K
Filed: Aug 11, 2026
Entity (CIK): 0000721371

Provenance trail

Filed with the SEC
Form 10-K, filed Aug 11, 2026.
Accession 0000721371-26-000038
Open in the Inline XBRL viewer for 0000721371-26-000038
Reported in the filing
Operating cash flow for fiscal year 2026, the period ended 2026-06-30, in USD. Valuein maps the filed line to the standard concept OperatingCashFlow.
Stored as one fact row
Every channel returns this row with the same id.
fact_id 5e3d4cdff9864529faa14d5b03db905ab2592530b974ce3cb2791cb726c955f4
Shown on this page
The same $5.17B appears in the Cash Flow Statement and in Cash & capital allocation.

fact rowjson

{  "entity_id": "0000721371",  "standard_concept": "OperatingCashFlow",  "fiscal_year": 2026,  "fiscal_period": "FY",  "period_end": "2026-06-30",  "numeric_value": 5174000000,  "unit": "USD",  "accession": "0000721371-26-000038",  "fact_id": "5e3d4cdff9864529faa14d5b03db905ab2592530b974ce3cb2791cb726c955f4"}

Get the same data

Get your free API key

bash

# Fact-level Parquet over HTTPS, every row traced to its filingcurl -H "Authorization: Bearer $VALUEIN_API_KEY" \  https://data.valuein.biz/v1/pro/fact/0000721371.parquet \  -o cah.parquet

Read the API docs

Terminalbash

# The same tables in your notebooks and backtests; the free sample needs no token$ pip install valuein-sdk

Python

from valuein_sdk import ValueinClient with ValueinClient() as client:    sql = """        SELECT fiscal_year, numeric_value FROM fact        WHERE entity_id = '0000721371'          AND standard_concept = 'TotalRevenue'          AND fiscal_period = 'FY'    """    print(client.run_query(sql))

Install the SDK

bash

# Connect Claude or ChatGPT to the same facts, each with a fact_idhttps://mcp.valuein.biz/mcp Ask your agent:get_company_fundamentals CAH   # CIK 0000721371

Connect the MCP server

bash

# Ask in plain English; every figure comes back cited to its filingTell me about CAH: a quick, cited overview I can dig into.

Open CAH in Workspace

One token unlocks every channel. SDK docs · MCP docs

Cite this page

Data as of Oct 30, 2026. Canonical address: https://valuein.biz/data/CAH

APA-style text

Valuein. (2026, October 30). CARDINAL HEALTH INC (CAH) financial statements, earnings power and smart-money summary [Data set]. Source: SEC EDGAR filings. https://valuein.biz/data/CAH

BibTeX

@misc{valuein_cah_2026,
  author = {{Valuein}},
  title = {CARDINAL HEALTH INC (CAH) financial statements, earnings power and smart-money summary},
  year = {2026},
  howpublished = {\url{https://valuein.biz/data/CAH}},
  note = {Data as of 2026-10-30; source: SEC EDGAR filings}
}

Open 10-K in SEC Inline XBRL viewer

10-K filed Aug 11, 2026 · accession 0000721371-26-000038

Agents: every figure Valuein's tools return carries a fact_id that traces to its SEC filing.

point-in-time · survivorship-free · every number traceable to its SEC filing

View CAH filings on SEC EDGAR

Index names are trademarks of their owners; Valuein is not affiliated with or endorsed by any index provider.

At a glance

Growth

Profitability

Per share

Insiders & holders

02Financial statements

Income Statement

Balance Sheet

Cash Flow Statement

Ratios & valuation

03Cash & capital allocation

Uses of operating cash flow, FY2026

Free cash flow by year

Buybacks by year

04Smart money

Insiders

Insider activity · past 12 months

Ownership

Largest institutional holders

Blockholders, 5% and over

Smart money

Aug 26, 1996 · 10-K

May 13, 1998 · 10-Q

Nov 1, 2024 · 10-Q

06Peers, filings & research

Sector Peers

Recent SEC filings

Research Reports

07The data behind this page

Fundamentals

Built from these SEC forms

Smart money

Built from these SEC forms

One real fact row for CARDINAL HEALTH INC

Provenance trail

Get the same data

08Cite this page

Insiders & holders

03Cash & capital allocation

Uses of operating cash flow, FY2026

Free cash flow by year

Buybacks by year

04Smart money

Insiders

Insider activity · past 12 months

Ownership

Largest institutional holders

Blockholders, 5% and over

Aug 26, 1996 · 10-K

May 13, 1998 · 10-Q

Nov 1, 2024 · 10-Q

Sector Peers

Recent SEC filings

07The data behind this page

Fundamentals

Built from these SEC forms

Smart money

Built from these SEC forms

One real fact row for CARDINAL HEALTH INC

Provenance trail

Get the same data

Financial statements

Cash & capital allocation

Smart money

Peers, filings & research

The data behind this page

Cite this page

Cash & capital allocation

Smart money

The data behind this page